Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidemiology of invasive meningococcal disease in 13 government hospitals in Thailand, 1994-1999.
Pancharoen C, Hongsiriwon S, Swasdichai K, Puthanakit T, Tangsathapornpong A, Lolekha S, Punpanich W, Tarunotai U, Warachit B, Mekmullica J, Kosalaraksa P, Chokephaibulkit K, Kerdpanich A. Pancharoen C, et al. Among authors: kosalaraksa p. Southeast Asian J Trop Med Public Health. 2000 Dec;31(4):708-11. Southeast Asian J Trop Med Public Health. 2000. PMID: 11414417
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immunogenicity in healthy infants (PNEU-DIRECTION).
Bili A, Dobson S, Quinones J, Phongsamart W, Oberdorfer P, Kosalaraksa P, Dagan R, Richmond P, Wilck M, Vallejos W, Nunn C, McFetridge R, Tamms G, Fu R, Lupinacci R, Musey L, Banniettis N, Bickham K; V114-027 PNEU-DIRECTION study group. Bili A, et al. Among authors: kosalaraksa p. Vaccine. 2023 Jan 16;41(3):657-665. doi: 10.1016/j.vaccine.2022.10.072. Epub 2022 Dec 13. Vaccine. 2023. PMID: 36522265 Clinical Trial.
Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine.
Kosuwon P, Warachit B, Hutagalung Y, Borkird T, Kosalaraksa P, Bock HL, Poovorawan Y. Kosuwon P, et al. Among authors: kosalaraksa p. Vaccine. 2003 Oct 1;21(27-30):4194-200. doi: 10.1016/s0264-410x(03)00496-1. Vaccine. 2003. PMID: 14505898 Clinical Trial.
Hospital-based epidemiologic survey of malignancies in children infected with human immunodeficiency virus in Thailand.
Pancharoen C, Nuchprayoon I, Thisyakorn U, Chokephaibulkit K, Veerakul G, Punpanich W, Kanjanapongkul S, Mekmullica J, Wongsawat J, Bowonkiratikachorn P, Hongsiriwon S, Thanarattanakorn P, Kosalaraksa P, Wiangnon S, Saerejittima A, Kochavate S. Pancharoen C, et al. Among authors: kosalaraksa p. Pediatr Infect Dis J. 2005 Oct;24(10):923-4. doi: 10.1097/01.inf.0000180972.63966.35. Pediatr Infect Dis J. 2005. PMID: 16220094
Primary vaccination with a new heptavalent DTPw-HBV/Hib-Neisseria meningitidis serogroups A and C combined vaccine is well tolerated.
Kerdpanich A, Warachit B, Kosuwon P, Gatchalian SR, Watanaveeradej V, Borkird T, Kosalaraksa P, Han HH, Hutagalung Y, Boutriau D, Dobbelaere K. Kerdpanich A, et al. Among authors: kosalaraksa p. Int J Infect Dis. 2008 Jan;12(1):88-97. doi: 10.1016/j.ijid.2007.06.002. Epub 2007 Aug 22. Int J Infect Dis. 2008. PMID: 17716936 Free article. Clinical Trial.
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Puthanakit T, Jourdain G, Hongsiriwon S, Suntarattiwong P, Chokephaibulkit K, Sirisanthana V, Kosalaraksa P, Petdachai W, Hansudewechakul R, Siangphoe U, Suwanlerk T, Ananworanich J; HIV-NAT 086Study Team. Puthanakit T, et al. Among authors: kosalaraksa p. HIV Med. 2010 Oct 1;11(9):565-72. doi: 10.1111/j.1468-1293.2010.00828.x. Epub 2010 Mar 25. HIV Med. 2010. PMID: 20345882 Free article.
High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited setting.
Puthanakit T, Jourdain G, Suntarattiwong P, Chokephaibulkit K, Siangphoe U, Suwanlerk T, Prasitsuebsai W, Sirisanthana V, Kosalaraksa P, Petdachai W, Hansudewechakul R, Waranawat N, Ananworanich J; HIV-NAT 086 study team. Puthanakit T, et al. Among authors: kosalaraksa p. AIDS Res Ther. 2012 Jun 18;9(1):20. doi: 10.1186/1742-6405-9-20. AIDS Res Ther. 2012. PMID: 22709957 Free PMC article.
Correlation of selenium and zinc levels to antiretroviral treatment outcomes in Thai HIV-infected children without severe HIV symptoms.
Bunupuradah T, Ubolyam S, Hansudewechakul R, Kosalaraksa P, Ngampiyaskul C, Kanjanavanit S, Wongsawat J, Luesomboon W, Pinyakorn S, Kerr S, Ananworanich J, Chomtho S, van der Lugt J, Luplertlop N, Ruxrungtham K, Puthanakit T; PREDICT study group. Bunupuradah T, et al. Among authors: kosalaraksa p. Eur J Clin Nutr. 2012 Aug;66(8):900-5. doi: 10.1038/ejcn.2012.57. Epub 2012 Jun 20. Eur J Clin Nutr. 2012. PMID: 22713768 Free PMC article. Clinical Trial.
154 results